Reflection Asset Management bought a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) in the fourth quarter, Holdings Channel reports. The fund bought 6,055 shares of the conglomerate’s stock, valued at approximately $1,386,000. Danaher accounts for 1.0% of Reflection Asset Management’s holdings, making the stock its 29th largest position.
Several other hedge funds have also bought and sold shares of DHR. Enterprise Financial Services Corp boosted its holdings in Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after buying an additional 46 shares in the last quarter. Kennebec Savings Bank increased its position in shares of Danaher by 1.4% in the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after buying an additional 46 shares in the last quarter. Revolve Wealth Partners LLC raised its stake in shares of Danaher by 2.6% during the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after buying an additional 47 shares during the period. High Note Wealth LLC lifted its position in shares of Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after buying an additional 47 shares in the last quarter. Finally, First Command Advisory Services Inc. lifted its position in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after buying an additional 47 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Stock Performance
Danaher stock opened at $177.74 on Friday. The firm has a 50 day simple moving average of $179.62 and a 200-day simple moving average of $203.07. The stock has a market cap of $125.80 billion, a price-to-earnings ratio of 34.38, a price-to-earnings-growth ratio of 2.26 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.
Wall Street Analyst Weigh In
A number of research firms have weighed in on DHR. TD Cowen reduced their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. UBS Group reduced their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a report on Friday, April 17th. Finally, DZ Bank began coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $233.61.
Read Our Latest Stock Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
